Skip to main content
. 2021 Jun 11;26(12):3577. doi: 10.3390/molecules26123577

Table 1.

Effect of test drugs administered in a single-dose or repeated-dose protocol and used alone or in combination on motor coordination of oxaliplatin-treated mice measured in the rotarod test.

Treatment
(Drug, Dose, Protocol)
Mean Time [s] (±SEM) on the Rotarod Revolving at:
6 rpm 18 rpm 24 rpm
Veh 60.0 ± 0.0 60.0 ± 0.0 47.0 ± 8.5
Veh + oxa 60.0 ± 0.0 60.0 ± 0.0 60.0 ± 0.0
Oxa + Mino 50 single
day 1
54.8 ± 5.3 60.0 ± 0.0 53.0 ± 7.0
Oxa + Mino 50 single
day 7
60.0 ± 0.0 60.0 ± 0.0 60.0 ± 0.0
Oxa + Mino 50 repeated day 7 60.0 ± 0.0 60.0 ± 0.0 60.0 ± 0.0
Oxa + Mino 100 single day 1 46.8 ± 8.7 48.3 ± 7.7 36.5 ± 9.1
Oxa + Mino 100 single day 7 46.0 ± 5.6 43.8 ± 10.2 42.7 ± 9.6
Oxa + Mino 100 repeated day 7 51.6 ± 5.5 60.0 ± 0.0 55.8 ± 2.8
Oxa + Mino 50 + Am 90 single day 1 57.5 ± 2.5 60.0 ± 0.0 58.3 ± 1.8
Oxa + Mino 50 + Am 90 single day 7 60.0 ± 0.0 60.0 ± 0.0 60.0 ± 0.0
Oxa + Mino 50 + Am 90 repeated day 7 60.0 ± 0.0 60.0 ± 0.0 60.0 ± 0.0
Oxa + Dulo 10 single
day 1
60.0 ± 0.0 49.6 ± 5.2 54.3 ± 3.8
Oxa + Dulo 10 single
day 7
52.9 ± 4.7 16.8 ± 3.5 **** 9.6 ± 1.7 ****
Oxa + Dulo 10 repeated day 7 60.0 ± 0.0 56.5 ± 2.3 56.0 ± 2.6
Oxa + Dulo 30 single
day 1
49.3 ± 7.0 36.0 ± 6.8 ** 23.5 ± 8.3 ***
Oxa + Dulo 30 single
day 7
44.7 2 6.0 49.5 ± 5.6 16.0 ± 2.8 ****
Oxa + Dulo 30 repeated day 7 54.8 ± 3.4 60.0 ± 0.0 28.8 ± 8.2 **
Oxa + Mino 50 + Dulo 10 single day 1 60.0 ± 0.0 49.8 ± 6.7 57.4 ± 1.7
Oxa + Mino 50 + Dulo 10 single day 7 60.0 ± 0.0 60.0 ± 0.0 48.9 ± 7.3
Oxa + Mino 50 + Dulo 10 repeated day 7 60.0 ± 0.0 49.4 ± 7.0 47.8 ± 7.2

The results are shown as the mean time [s] (± SEM) spent on the rotarod apparatus revolving at 6, 18, and 24 rpm for n = 6–8. Statistical analysis: one-way ANOVA followed by Tukey’s post-hoc comparison. Significance vs. vehicle + oxaliplatin-treated mice: ** p < 0.01, *** p < 0.001, **** p < 0.0001. Abbreviations: Veh—vehicle, Oxa—oxaliplatin, Mino—minocycline, Am—ambroxol, Dulo—duloxetine.